Gilead Sciences, Inc.GILD

Where GILD's Net Debt / EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$151.00-0.22 (-0.15%)Previous close
NASDAQHealthcare

GILD Net Debt / EBITDA: current value, 10-year range and year-by-year history

Net Debt / EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
GILD Net Debt / EBITDA historyGILD Net Debt / EBITDA from Sep 2023 to Jun 2026: low 1.04, high 36.27, latest 36.27.-1.788.4418.6528.8739.09Sep 23Mar 24Sep 24Jun 25Dec 25Jun 26med 1.8

GILD Net Debt / EBITDA by year

Yearly range of GILD’s net debt / ebitda from 2016 to 2026. Over the full period it ranged from 0.8 to 36.3, averaging 3.2.

GILD Net Debt / EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
20261.018.736.336.3
20251.31.51.81.3
20243.94.24.63.9
20231.81.92.01.9
20222.22.52.72.2
20211.93.05.81.9
20202.05.49.66.1
20190.91.62.31.7
20180.91.21.50.9
20170.91.11.61.6
20160.80.90.90.9

Get notified when GILD Net Debt / EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How many years of operating earnings it would take to pay off the company's net debt. The most common leverage ratio — higher means more financial risk and less flexibility.

Formula(Total Debt − Cash) / EBITDA
Full guide
How to read this chart

Watch the trend more than the level. Declining ratio = deleveraging, growing financial flexibility. Rising ratio = increasing leverage, which constrains dividends, buybacks, and future investment.

Key caveats
  • Sector context is essential: 3× is aggressive for a consumer brand but normal for a regulated utility. Always compare to sector peers.
  • Large acquisitions spike the ratio temporarily — check whether the integration plan credibly drives paydown.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.